BioLine Rx Ltd ADR (NASDAQ:BLRX) - Overview

Stock Report

BioLine Rx Ltd BLRX

Last Price
$0.99

Day Change
-0.04|-3.88%

As of 06/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close1.03
Day Range0.99 - 1.05
Mkt Cap58.13Mil
52-Wk Range0.71 - 1.50
Yield %-
ISINUS09071M1062
Volume160,086
P/E-3.54
P/S-
P/CF-4.04

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.000.000.00
Operating Income-17.63-15.85-16.20
Net Income-17.64-10.17-14.40
Basic EPS-0.78-0.31-0.28
Avg. Diluted Shares Outstanding223251
Balance Sheet
Current Assets18.7735.1148.18
Non Current Assets1.171.053.12
Total Assets19.9536.1751.30
Current Liabilities3.002.903.14
Total Liabilities8.274.403.69
Total Equity11.6831.7747.61
Cash Flow
Operating Cash Flow-20.23-14.48-14.17
Capital Expenditure-0.12-0.18-2.72
Free Cash Flow-20.35-14.66-16.89

In millions, except "Basic EPS". Currency is USD.

Company Profile

BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

48
Key Stats
More ...
Price/Earning TTM-3.68
Price/Book1.51
Price/Sales TTMInfinity
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.